(2-Methyl-6-trifluoromethyl-pyridin-3-yl)-phenyl-methanone, 95.0%, 1g

H-Tyr(3-l)-OH, 95%, 5g

(2E)-3-(3-bromophenyl)-1-(3-chlorophenyl)prop-2-en-1-one, 95.0%, 10g

3-Methoxy-4-nitrobenzoic acid, 98.0%, 10g

1-(Bromomethyl)-2,4-dichlorobenzene, 95.0%, 250mg

5-Methoxy-1-methyl-1H-benzo[d]imidazole, 95.0%, 5g

Thiazol-2-ylmethanamine>95.0%(GC)(T)200mg

Thieno[2,3-d]pyrimidine-2,4-diol, 95.0%, 5g

anti-Keratin K17 mouse monoclonal, Ks17.E3, 0.2 ml

5-Bromo-2-chloro-4-fluorobenzenesulfonyl chloride, 1g

Cyclohexane-1,4-diyldimethanamine (cis- and trans- mixture), 95.0%, 10g

3-(1-Naphthyl)acrylic Acid>95.0%(GC)5g

4-(Difluoromethoxy)-2-fluorobenzyl bromide, 5g